Exact Sciences Announces Third Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Exact Sciences (EXAS) Tops Q3 EPS by 23c
November 3, 2022 4:15 PM EDTExact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.84), $0.23 better than the analyst estimate of ($1.07). Revenue for the quarter came in at $523.1 million versus the consensus estimate of $503.13 million.
GUIDANCE:
Exact Sciences sees FY2022 revenue of $2.025-2.042 billion, versus the consensus... More



